M&A Deal Summary

Agenus Acquires Celexion - Key Antibody Assets

On April 8, 2015, Agenus acquired life science company Celexion - Key Antibody Assets from Celexion for 4M USD

Acquisition Highlights
  • This is Agenus’ 2nd transaction in the Life Science sector.
  • This is Agenus’ 2nd largest (disclosed) transaction.
  • This is Agenus’ 1st transaction in the United States.
  • This is Agenus’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2015-04-08
Target Celexion - Key Antibody Assets
Sector Life Science
Buyer(s) Agenus
Sellers(s) Celexion
Deal Type Divestiture
Deal Value 4M USD

Target

Celexion - Key Antibody Assets

Cambridge, Massachusetts, United States
Celexion's Key Antibody Assets is a SECANT yeast display platform for the generation of novel monoclonal antibodies. SECANT is designed to enable highly efficient interrogation of drug targets such as checkpoint proteins.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Agenus

Lexington, Massachusetts, United States
Category Company
Founded 1994
Sector Life Science
Employees389
Revenue 156M USD (2023)
DESCRIPTION

Agenus is a biotechnology company developing treatments for cancers and infectious diseases. Agenus was incorporated in 1994 and is based in Lexington, Massachusetts.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 3
Type (Divestiture) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 2
Year (2015) 1 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-13 4-Antibody AG

Basel, Switzerland

4-Antibody AG, a private European-based biopharmaceutical company.

Buy $40M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-23 PhosImmune

Charlottesville, Virginia, United States

PhosImmune, Inc. is a developer of therapeutic cancer vaccines.

Buy -

Seller(S) 1

SELLER

Celexion

Cambridge, Massachusetts, United States
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Celexion LLC is a bioengineering company that develops powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and life science research sectors.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal